IXC 2.86% 7.2¢ invex therapeutics ltd

Ann: Invex Receives Written Response from FDA on Type C Meeting, page-14

  1. 2,931 Posts.
    lightbulb Created with Sketch. 1303
    https://www.fda.gov/patients/drug-development-process/step-3-clinical-research

    This isn't probably the best link to FDA site, but was best I could quickly find.... read the very last paragraph.

    One site has to be done on US. Other can be anywhere else (like EU as part of EMA approval).. only catch is both trial designs have to be acceptable to FDA
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $1.701K 23.62K

Buyers (Bids)

No. Vol. Price($)
2 76375 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.